Dallas / Boston / New York / Columbus / San Diego / Durham / /
Company
GlobeImmune Inc. / Anaeropharma Science Inc. / Tocagen Inc. / /
Event
FDA Phase / Product Issues / /
Facility
Ohio State University Medical Center / Children’s Hospital / National Cancer Institute / Mary Crowley Cancer Research Center / Duke University Medical Center / Memorial-Sloan Kettering Cancer Center / /
MedicalCondition
Recurrent High Grade Glioma / Metastatic Solid Tumors PI / /
MedicalTreatment
Gene Therapy / /
Organization
Harvard Medical School / National Cancer Institute / FC PI / National Institute of Health / Ohio State University Medical Center / Intracoronary Administration of MYDICAR / Children’s Hospital Boston / 126th Meeting Rockville Hilton & Executive Meeting Center / RECOMBINANT DNA ADVISORY COMMITTEE / Mary Crowley Cancer Research Center / office of Biotechnology Activities / Memorial-Sloan Kettering Cancer Center / Duke University Medical Center / /
Person
Bernard Roizman / S. Tab / Marshall Strome / M.S. Anna Mastroianni / David A. Williams / Jim Yankaskas / Sung-Yun Pai / Celladon / Yuman Fong / M.S. James Yankaskas / Rebecca H. Buckley / D. Norman Fost / J.D. David Ornelles / E. Antonio Chiocca / Dan Pertschuk / John J. Nemunaitis / M.D. Marshall Strome / Susan Ross / Andrew Badley / M.D. Susan Ross / James L. Gulley / Walter Koch / D. E. Antonio Chiocca / Joseph Kanabrocki / Barry Anderson / M.D. Donald Kohn / M.D. Michael Buchmeier / Jacqueline Corrigan-Curay / M.P.H. Marcella Sarzotti-Kelsoe / Bethesda / Donald Kohn / Doug Jolly / Krisztina Zsebo / / /
Position
Acting Director / Professor / Chair / Marshall / Chief Executive Officer and President / /
NATIONAL INSTITUTES OF HEALTH